Evidence map›Paper›PMID 9602995›Full record

ArticleJournal of medical ethics1998

Supply of medicines: paternalism, autonomy and reality.

D Prayle, M Brazier

Abstract read
In one paragraph

Article in Journal of medical ethics, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. How to Regulate the Right to Self-Medicate.HEC forum : an interdisciplinary journal on hospitals' ethical and legal issues · 2022
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Primary care groups and the right to prescribe.BMJ (Clinical research ed.) · 1998
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

D PrayleInstitute of Medicine, Law and Bioethics, University of Manchester.
M Brazier

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radical changes are taking place in the United Kingdom in relation to the classification of, and access to, medicines. More and more medicines are being made available over the counter both in local pharmacies and in supermarkets. The provision of more open access to medicines may be hailed as a triumph for patient autonomy. This paper examines whether such a claim is real or illusory. It explores the ethical and legal implications of deregulating medicines. Do patients benefit? What is the impact on pharmacists? Are the true beneficiaries of change largely the pharmaceutical industries?

Indexed as

Government RegulationHealth Services AccessibilityLegislation, DrugPaternalismPersonal AutonomyPharmaceutical PreparationsProfessional RoleBeneficenceCultural CharacteristicsHumansInformation DisseminationPharmacyPhilosophy, MedicalRisk AssessmentUnited KingdomPharmaceutical PreparationsBioethics and Professional EthicsLegal ApproachMedicines Act 1968 (Great Britain)Medicines Control Agency (Great Britain)National Health ServiceProfessional Patient Relationship

Identifiers

PMID9602995
PMCPMC1377453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.